[Pharmacological properties of T-817MA, a novel neurotrophic agent, for treatment of Alzheimer's disease.].
Fukushima
Tetsuo
T
TETUO_FUKUSHIMA@toyama-chemical.co.jp
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D016229:Amyloid beta-Peptides; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D008298:Maleates / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D009414:Nerve Growth Factors / Q000494:pharmacology* / Q000627:therapeutic use; D016501:Neurites / Q000502:physiology; D018696:Neuroprotective Agents; D051381:Rats; D013876:Thiophenes / Q000494:pharmacology* / Q000627:therapeutic use; D016875:tau Proteins
C503102:1-(3-(2-(1-benzothiophen-5-yl) ethoxy) propyl)-3-azetidinol maleate; D016229:Amyloid beta-Peptides; D008298:Maleates; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents; D013876:Thiophenes; D016875:tau Proteins